经心尖二尖瓣置换术中穿刺点管理
该欧洲多中心回顾性研究分析了127例经心尖二尖瓣置换患者的CT、手术记录与规划资料,比较发生与未发生心尖入路并发症(AAC)的患者。AAC发生率为6.3%,多出现于各中心前10例,且与心肌较薄、手术时间延长、循环支持及瓣膜回收率更高相关,并显著增加30天及院内死亡风险。
要点
- AAC发生率6.3%,多集中于各中心早期病例。
- AAC与目标穿刺点心肌较薄、手术时间延长及循环支持使用相关。
- AAC显著增加30天及院内死亡风险,需重视筛查与手术培训。
核心结论
- 经心尖二尖瓣置换术中的心尖入路并发症虽相对少见,但与较差的短期结局相关。
- 关注筛选过程中的心尖心肌情况并开展针对性手术培训,可能避免AAC并改善结局。
研究设计与样本
- 欧洲15中心参与的观察性研究,回顾性分析127例使用Tendyne瓣膜系统行经心尖二尖瓣置换患者的CT扫描、手术报告和规划幻灯片。
- 比较发生AAC(A组)与未发生AAC(B组)患者之间的差异。
主要发现
- 共记录8例(6.3%)AAC,其中7例发生于各中心前10例患者。
- AAC组目标穿刺点心肌厚度中位数为4.4 mm,无AAC组为6.1 mm(P = .086)。
- AAC组手术时间中位数180 min,无AAC组123 min(P = .011)。
- AAC组循环支持使用率50%,无AAC组0%(P < .001);瓣膜回收率38% vs 3%(P = .005);紧急全胸骨切开率13% vs 0%(P = .063)。
- AAC组术中死亡率25%(vs 0%,P = .010),院内死亡率50%(vs 7%,P = .003);AAC显著增加30天死亡风险(调整OR 19.5;95%CI 2.19-178.3;P = .008)和院内死亡风险(调整HR 9.00;95%CI 1.95-41.42;P = .005)。
临床怎么用
- 在术前筛查中应关注心尖目标穿刺点的心肌厚度,警惕心肌较薄的患者。
- 开展经心尖二尖瓣置换术的中心应注重手术技术培训,尤其是早期病例。
- 术中若遇技术困难应警惕AAC可能,并及时处理以降低死亡风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The role of the surgical technique and anatomy in transapical mitral valve replacement are scarcely investigated. METHODS: Computed tomography scans, surgical reports and planning slides of 127 patients undergoing transapical mitral valve replacement with the Tendyne valve system (Abbott Vascular) at 15 centers, participating in a European observational study, were retrospectively analyzed and compared between patients with (cohort A) and without (cohort B) apical access complications (AACs). RESULTS: A total of 8 (6.3%) AACs were recorded, of which 7 of 8 were observed in the first 10 patients of the respective center. Patients with AACs showed a trend to a thinner myocardium at the target access compared with those with regular access (median 4.4 vs 6.1 mm, P = .086). Technical difficulties along with AACs were reflected by a significant longer procedural time (median 180 vs 123 min, P = .011), higher rates of circulation support (50% vs 0%, P < .001), valve retrieval (38% vs 3%, P = .005), and bailout full sternotomy (13% vs 0%, P = .063). AACs were related with an intraprocedural mortality and in-hospital mortality rate of 25% (vs 0%, P = .010) and 50% (vs 7%, P = .003), respectively. In total, 8 of 12 in-hospital deaths were attributed to AACs and/or sepsis. AACs significantly increased the risk for 30-day (adjusted odds ratio, 19.5; 95% CI, 2.19-178.3; P = .008) and in-hospital mortality (adjusted hazard ratio, 9.00; 95% CI, 1.95-41.42; P = .005). CONCLUSIONS: Access complications in transapical mitral valve replacement are relatively rare but associated with poor short-term outcome. Focus on the apical myocardium within the screening process and specific surgical training might avoid AACs and improve outcome.
引用
- Kerbel T, Wild MG, Hell MM, et al. Apical Access Management in Transapical Transcatheter Mitral Valve Replacement. Ann Thorac Surg. 2025. PMID: 40015546. doi:10.1016/j.athoracsur.2025.01.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。